IN-DATE
PM3222: SJM Allure RF Cardiac Resynchronization Therapy Pacemaker
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $1,176.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 15 hours 37 minutes and choose overnight shipping at checkout. |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Additional Details
Allure RF Pacemaker
PM3222
- Dimensions: 55mm x 59mm x 6mm
- Weight: 24g
- Volume: 14cc
- Connector: IS-1
AccessGUDID Info
- FDA Product Code: NIK
- FDA Product Code Name: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
- GMDN Term Code: 47263
- GMDN Term Name: Cardiac resynchronization therapy implantable pacemaker
- GMDN Term Description: A battery-powered, hermetically-sealed pulse generator, intended to be implanted beneath the skin of the chest in a surgically-created pocket, and used with pacing leads placed in the right ventricle, in a coronary vein over the left ventricle, and often in the right atrium (triple chamber) to stimulate the heart to beat at a faster rate when it senses bradycardia and provides cardiac resynchronization therapy (CRT) through biventricular electrical stimulation to synchronize right and left ventricular contractions to treat symptoms of heart failure (e.g., easy fatigue) and serious heart-rhythm problems [CRT pacemaker (CRT-P)]; it is not intended for defibrillation therapy.
Manufacturer
Abbott St. Jude Medical has long been a leader in vascular care, through its stents and related products. And, in recent years, the company has built a strong position in mitral valve repair with its MitraClip device. The agreement to acquire St. Jude Medical broadens Abbott's presence in virtually every aspect of cardiovascular care, and will make Abbott one of the world leaders in the broad medical device market.
